In cases with HER2+ BC from the TCGA-BRCA dataset, we found 6,259 DEGs, of which, 3,252 were upregulated and 3,006 were downregulated between breast cancer and precancerous normal samples. This evidence concerns the gene ERBB2 and breast cancer.